2015-2027 Global Small Molecule Cancer Drug Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 140 pages | ID: 225E94A9A855EN
Maia Research

Abstracts

The worldwide market for Small Molecule Cancer Drug is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Johnson & Johnson
Astrazeneca
Novartis
Eli Lily
Merck
Cadila Pharmaceutical
Roche
Bayer
Boehringer Ingelheim

Major Types Covered
Cytokine
Humanized Monoclonal Antiboby
Others

Major Applications Covered
Lymphoma
Myeloma
Prostate Cancer

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Small Molecule Cancer Drug Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Small Molecule Cancer Drug Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE SMALL MOLECULE CANCER DRUG MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL SMALL MOLECULE CANCER DRUG MARKET-SEGMENTATION BY TYPE

5.1 Cytokine
5.2 Humanized Monoclonal Antiboby
5.3 Others

6 GLOBAL SMALL MOLECULE CANCER DRUG MARKET-SEGMENTATION BY APPLICATION

6.1 Lymphoma
6.2 Myeloma
6.3 Prostate Cancer

7 GLOBAL SMALL MOLECULE CANCER DRUG MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Johnson & Johnson
  8.1.1 Johnson & Johnson Profile
  8.1.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.1.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.2 Astrazeneca
  8.2.1 Astrazeneca Profile
  8.2.2 Astrazeneca Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Astrazeneca Product/Solution Launches and Enhancements Analysis
  8.2.4 Astrazeneca Business Overview/Recent Development/Acquisitions
8.3 Novartis
  8.3.1 Novartis Profile
  8.3.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.3.4 Novartis Business Overview/Recent Development/Acquisitions
8.4 Eli Lily
  8.4.1 Eli Lily Profile
  8.4.2 Eli Lily Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Eli Lily Product/Solution Launches and Enhancements Analysis
  8.4.4 Eli Lily Business Overview/Recent Development/Acquisitions
8.5 Merck
  8.5.1 Merck Profile
  8.5.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Merck Product/Solution Launches and Enhancements Analysis
  8.5.4 Merck Business Overview/Recent Development/Acquisitions
8.6 Cadila Pharmaceutical
  8.6.1 Cadila Pharmaceutical Profile
  8.6.2 Cadila Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Cadila Pharmaceutical Product/Solution Launches and Enhancements Analysis
  8.6.4 Cadila Pharmaceutical Business Overview/Recent Development/Acquisitions
8.7 Roche
  8.7.1 Roche Profile
  8.7.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Roche Product/Solution Launches and Enhancements Analysis
  8.7.4 Roche Business Overview/Recent Development/Acquisitions
8.8 Bayer
  8.8.1 Bayer Profile
  8.8.2 Bayer Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Bayer Product/Solution Launches and Enhancements Analysis
  8.8.4 Bayer Business Overview/Recent Development/Acquisitions
8.9 Boehringer Ingelheim
  8.9.1 Boehringer Ingelheim Profile
  8.9.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
  8.9.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions

9 GLOBAL SMALL MOLECULE CANCER DRUG MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Small Molecule Cancer Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Small Molecule Cancer Drug Production Analysis from 2015-2020
10.4 North America Small Molecule Cancer Drug Consumption Analysis from 2015-2020
10.5 North America Small Molecule Cancer Drug Import and Export from 2015-2020
10.6 North America Small Molecule Cancer Drug Value, Production and Market Share by Type (2015-2020)
10.7 North America Small Molecule Cancer Drug Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Small Molecule Cancer Drug by Country (United States, Canada)
  10.8.1 North America Small Molecule Cancer Drug Sales by Country (2015-2020)
  10.8.2 North America Small Molecule Cancer Drug Consumption Value by Country (2015-2020)
10.9 North America Small Molecule Cancer Drug Market PEST Analysis

11 EUROPE

11.1 Europe Small Molecule Cancer Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Small Molecule Cancer Drug Production Analysis from 2015-2020
11.4 Europe Small Molecule Cancer Drug Consumption Analysis from 2015-2020
11.5 Europe Small Molecule Cancer Drug Import and Export from 2015-2020
11.6 Europe Small Molecule Cancer Drug Value, Production and Market Share by Type (2015-2020)
11.7 Europe Small Molecule Cancer Drug Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Small Molecule Cancer Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Small Molecule Cancer Drug Sales by Country (2015-2020)
  11.8.2 Europe Small Molecule Cancer Drug Consumption Value by Country (2015-2020)
11.9 Europe Small Molecule Cancer Drug Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Small Molecule Cancer Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Small Molecule Cancer Drug Production Analysis from 2015-2020
12.4 Asia-Pacific Small Molecule Cancer Drug Consumption Analysis from 2015-2020
12.5 Asia-Pacific Small Molecule Cancer Drug Import and Export from 2015-2020
12.6 Asia-Pacific Small Molecule Cancer Drug Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Small Molecule Cancer Drug Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Small Molecule Cancer Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Small Molecule Cancer Drug Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Small Molecule Cancer Drug Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Small Molecule Cancer Drug Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Small Molecule Cancer Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Small Molecule Cancer Drug Production Analysis from 2015-2020
13.4 Latin America Small Molecule Cancer Drug Consumption Analysis from 2015-2020
13.5 Latin America Small Molecule Cancer Drug Import and Export from 2015-2020
13.6 Latin America Small Molecule Cancer Drug Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Small Molecule Cancer Drug Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Small Molecule Cancer Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Small Molecule Cancer Drug Sales by Country (2015-2020)
  13.8.2 Latin America Small Molecule Cancer Drug Consumption Value by Country (2015-2020)
13.9 Latin America Small Molecule Cancer Drug Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Small Molecule Cancer Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Small Molecule Cancer Drug Production Analysis from 2015-2020
14.4 Middle East & Africa Small Molecule Cancer Drug Consumption Analysis from 2015-2020
14.5 Middle East & Africa Small Molecule Cancer Drug Import and Export from 2015-2020
14.6 Middle East & Africa Small Molecule Cancer Drug Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Small Molecule Cancer Drug Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Small Molecule Cancer Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Small Molecule Cancer Drug Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Small Molecule Cancer Drug Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Small Molecule Cancer Drug Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL SMALL MOLECULE CANCER DRUG MARKET FROM 2020-2027

15.1 Future Forecast of the Global Small Molecule Cancer Drug Market from 2020-2027 Segment by Region
15.2 Global Small Molecule Cancer Drug Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Small Molecule Cancer Drug Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Small Molecule Cancer Drug Market Value ($) and Growth Rate of Small Molecule Cancer Drug from 2015-2027
Global Small Molecule Cancer Drug Production and Growth Rate Segment by Product Type from 2015-2027
Global Small Molecule Cancer Drug Consumption and Growth Rate Segment by Application from 2015-2027
Figure Small Molecule Cancer Drug Picture
Table Product Specifications of Small Molecule Cancer Drug
Table Driving Factors for this Market
Table Industry News of Small Molecule Cancer Drug Market
Figure Value Chain Status of Small Molecule Cancer Drug
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Small Molecule Cancer Drug Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Small Molecule Cancer Drug Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Cytokine of Small Molecule Cancer Drug
Figure Humanized Monoclonal Antiboby of Small Molecule Cancer Drug
Figure Others of Small Molecule Cancer Drug
Table Global Small Molecule Cancer Drug Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Small Molecule Cancer Drug Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Lymphoma of Small Molecule Cancer Drug
Figure Myeloma of Small Molecule Cancer Drug
Figure Prostate Cancer of Small Molecule Cancer Drug
Table Global Small Molecule Cancer Drug Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Small Molecule Cancer Drug Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Small Molecule Cancer Drug
Figure Online Channel of Small Molecule Cancer Drug
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Astrazeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure Astrazeneca Sales and Growth Rate from 2015-2020
Figure Astrazeneca Revenue ($) and Global Market Share from 2015-2020
Table Astrazeneca Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lily Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lily Sales and Growth Rate from 2015-2020
Figure Eli Lily Revenue ($) and Global Market Share from 2015-2020
Table Eli Lily Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Cadila Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region)
Figure Cadila Pharmaceutical Sales and Growth Rate from 2015-2020
Figure Cadila Pharmaceutical Revenue ($) and Global Market Share from 2015-2020
Table Cadila Pharmaceutical Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2015-2020
Figure Roche Revenue ($) and Global Market Share from 2015-2020
Table Roche Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bayer Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer Sales and Growth Rate from 2015-2020
Figure Bayer Revenue ($) and Global Market Share from 2015-2020
Table Bayer Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim Small Molecule Cancer Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Small Molecule Cancer Drug Production Value ($) by Region from 2015-2020
Table Global Small Molecule Cancer Drug Production Value Share by Region from 2015-2020
Table Global Small Molecule Cancer Drug Production by Region from 2015-2020
Table Global Small Molecule Cancer Drug Consumption Value ($) by Region from 2015-2020
Table Global Small Molecule Cancer Drug Consumption by Region from 2015-2020
Table North America Small Molecule Cancer Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Small Molecule Cancer Drug Import and Export from 2015-2020
Table North America Small Molecule Cancer Drug Value ($) by Type (2015-2020)
Table North America Small Molecule Cancer Drug Production by Type (2015-2020)
Table North America Small Molecule Cancer Drug Consumption by Application (2015-2020)
Table North America Small Molecule Cancer Drug Consumption by Country (2015-2020)
Table North America Small Molecule Cancer Drug Consumption Value ($) by Country (2015-2020)
Figure North America Small Molecule Cancer Drug Market PEST Analysis
Table Europe Small Molecule Cancer Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Small Molecule Cancer Drug Import and Export from 2015-2020
Table Europe Small Molecule Cancer Drug Value ($) by Type (2015-2020)
Table Europe Small Molecule Cancer Drug Production by Type (2015-2020)
Table Europe Small Molecule Cancer Drug Consumption by Application (2015-2020)
Table Europe Small Molecule Cancer Drug Consumption by Country (2015-2020)
Table Europe Small Molecule Cancer Drug Consumption Value ($) by Country (2015-2020)
Figure Europe Small Molecule Cancer Drug Market PEST Analysis
Table Asia-Pacific Small Molecule Cancer Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Small Molecule Cancer Drug Import and Export from 2015-2020
Table Asia-Pacific Small Molecule Cancer Drug Value ($) by Type (2015-2020)
Table Asia-Pacific Small Molecule Cancer Drug Production by Type (2015-2020)
Table Asia-Pacific Small Molecule Cancer Drug Consumption by Application (2015-2020)
Table Asia-Pacific Small Molecule Cancer Drug Consumption by Country (2015-2020)
Table Asia-Pacific Small Molecule Cancer Drug Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Small Molecule Cancer Drug Market PEST Analysis
Table Latin America Small Molecule Cancer Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Small Molecule Cancer Drug Import and Export from 2015-2020
Table Latin America Small Molecule Cancer Drug Value ($) by Type (2015-2020)
Table Latin America Small Molecule Cancer Drug Production by Type (2015-2020)
Table Latin America Small Molecule Cancer Drug Consumption by Application (2015-2020)
Table Latin America Small Molecule Cancer Drug Consumption by Country (2015-2020)
Table Latin America Small Molecule Cancer Drug Consumption Value ($) by Country (2015-2020)
Figure Latin America Small Molecule Cancer Drug Market PEST Analysis
Table Middle East & Africa Small Molecule Cancer Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Small Molecule Cancer Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Small Molecule Cancer Drug Import and Export from 2015-2020
Table Middle East & Africa Small Molecule Cancer Drug Value ($) by Type (2015-2020)
Table Middle East & Africa Small Molecule Cancer Drug Production by Type (2015-2020)
Table Middle East & Africa Small Molecule Cancer Drug Consumption by Application (2015-2020)
Table Middle East & Africa Small Molecule Cancer Drug Consumption by Country (2015-2020)
Table Middle East & Africa Small Molecule Cancer Drug Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Small Molecule Cancer Drug Market PEST Analysis
Table Global Small Molecule Cancer Drug Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Small Molecule Cancer Drug Production and Growth Rate Forecast by Region (2020-2027)
Table Global Small Molecule Cancer Drug Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Small Molecule Cancer Drug Production and Growth Rate Forecast by Type (2020-2027)
Table Global Small Molecule Cancer Drug Consumption and Growth Rate Forecast by Application (2020-2027)